Think long-term: View your GLP-1 medication as an aid, not the main component
The 3 mg dose is for initial dosing and inadequate for glycemic control
Driven by: Obesity & metabolic syndrome awareness Expanded indications (NASH, PCOS, heart failure, etc.) Employer & insurer push for weight-loss coverage Global access to GLP-1 drugs could save 2.1-3.1 million lives a year
Without systematic tracking, you are guessing about your protocol effectiveness, and guessing leads to premature dose changes, unnecessary escalation, and abandoned protocols that might have worked with more patience
Understanding how these medications interact with your body is important, particularly if you have pre-existing kidney conditions
The peptides anti-inflammatory effects offer pain relief and help promote tissue repair